Stendra
Product Images NDC 72384-752

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Stendra (NDC 72384-752). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Metuchen Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Following Structural Formula For Avanafil Occurs As White Crystalline Powder, Molecular Formula C23h26cln7o3 And Molecular Weight Of 483.95 And Is Slightly Soluble In Ethanol, Practically Insoluble In Water, Soluble In 0.1 Mol/l Hydrochloric Acid. Stendra, For Oral Administration, Is Supplied As Oval, Pale Yellow Tablets Containing 50 mg, 100 mg, Or 200 mg Avanafil Debossed With Dosage Strengths. In Addition To The Active Ingredient, Avanafil, Each Tablet Contains The Following Inactive Ingredients: Mannitol, Fumaric Acid, Hydroxypropylcellulose, Low Substituted Hydroxypropylcellulose, Calcium Carbonate, Magnesium Stearate, And Ferric Oxide Yellow. (Stendra 01)

Chemical structure diagram of the active ingredient in Stendra, showing the molecular arrangement of atoms and bonds in the compound. The image depicts ring structures, functional groups, and various atoms connected as part of the molecule's architecture.*

FDA Label Image

Figure 1: Median Change From Baseline In Sitting Systolic Blood Pressure, Healthy Volunteers Day 4 (Stendra 02)

A line graph depicting systolic blood pressure changes over time post dose, comparing Avanafil 200 mg and placebo. The x-axis represents time in hours post dose, and the y-axis shows systolic blood pressure in mmHg. Two lines illustrate the blood pressure trends for Avanafil 200 mg and placebo groups over a 2-hour period.*

FDA Label Image

Figure 2: Mean (sd) Change From Baseline In Standing Systolic Blood Pressure Over Time Following Administration Of A Single Dose 200 mg Dose Of Stendra With Doxazosin (Stendra 03)

A line graph comparing the effects of Avanafil 200 mg and placebo on a variable measured in mmHg over a 6-hour period post dosing. The x-axis represents hours from dosing (0 to 6), while the y-axis shows the measurement in mmHg ranging from -10 to 20. Data points for both Avanafil and placebo are plotted with error bars indicating variability.*

FDA Label Image

Figure 3: Mean (sd) Change From Baseline In Standing Systolic Blood Pressure Over Time Following Administration Of A Single Dose 200 mg Dose Of Stendra With Tamsulosin (Stendra 04)

A line graph comparing changes in mmHg over a 6-hour period from dosing, showing two groups labeled Avanafil 200 mg and Placebo. The x-axis represents hours from dosing (0 to 6), and the y-axis represents mmHg changes (ranging from -10 to 20). Each data point includes error bars indicating variability.*

FDA Label Image

Figure 4: Plasma Avanafil Concentrations (mean ± Sd) Following A Single 50 mg Or 200 mg Stendra Dose (Stendra 05)

A pharmacokinetic curve showing plasma concentration (ng/mL) versus time (hours) for two dosages, 50 mg and 200 mg. The graph plots concentration decline over 24 hours with error bars, illustrating drug levels at various time points.*

FDA Label Image

Principal Display Panelndc 76299-320-85stendra(avanafil) Tablets50 mgrx Only30 Tablets (Stendra 07)

Stendra 50 mg tablets label showing the active ingredient avanafil. The label indicates prescription only (Rx only) status and a package count of 30 tablets. Labeler is Metuchen Pharmaceuticals, LLC. Storage and handling instructions are partially visible, including temperature range and light protection guidance.*

FDA Label Image

Principal Display Panelndc 76299-321-85stendra(avanafil) Tablets100 mgrx Only30 Tablets (Stendra 08)

Stendra 100 mg (avanafil) tablets label showing the medication strength and count of 30 tablets. The label includes the National Drug Code (NDC) 72384-752-30 and indicates it is Rx only. It is labeled by Metuchen Pharmaceuticals, LLC. Additional storage, dosage, and safety instructions appear on the label.*

FDA Label Image

Principal Display Panelndc 76299-322-85stendra(avanafil) Tablets200 mgrx Only30 Tablets (Stendra 09)

Label for Stendra (avanafil) tablets, 200 mg strength. The label shows the product is prescription only with a package count of 30 tablets. It includes the NDC number 72384-753-30 and is labeled by Metuchen Pharmaceuticals, LLC. Storage and protection instructions are printed on the right side of the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.